XTX Topco’s HCW Biologics HCWB Stock Holding History

XTX Topco’s Portfolio HCWB Stock Details HCWB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-142	Closed	-$15.2K	–	2664
2024 Q4	$15.2K	Buy	+142	New	+$16.6K	﹤0.01%	2088

Other funds holding HCWB

APP

Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

PIM

Pullen Investment Management Bradenton, Florida $216M AUM 32.94% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

XTX Topco's HCWB Position: Q1 2025 in Review

XTX Topco sold out of HCW Biologics (HCWB) in Q1 2025, closing a stake of 142 shares — an estimated $15.2K sold.

XTX Topco first reported a position in HCWB in Q4 2024 and held it in 1 quarter. The position peaked at $15.2K in Q4 2024. 14 funds tracked by Wall St. Rank hold HCWB as of Q1 2025.

XTX Topco reported no remaining HCW Biologics position as of Q1 2025 after selling out during the quarter.
XTX Topco sold 142 HCW Biologics shares in Q1 2025, an estimated $15.2K.
XTX Topco first reported a position in HCW Biologics in Q4 2024 and held it in 1 quarter.
XTX Topco's HCW Biologics position peaked at $15.2K in Q4 2024.
14 funds tracked by Wall St. Rank held HCW Biologics as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.